Uncapping NF-κB activity in pancreatic cancer

被引:4
|
作者
Gurumurthy, Sushma [1 ]
Bardeesy, Nabeel [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA
来源
EMBO JOURNAL | 2011年 / 30卷 / 01期
关键词
REVEALS; MODEL;
D O I
10.1038/emboj.2010.324
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Living cells must be capable of rapidly responding to intrinsic and environmental cues to ensure normal development and homeostasis. The NF-kappa B transcription factor mediates a series of such rapid-response programs, serving as a master regulator of gene transcription in cells subjected to inflammation, irradiation, or other stress states (Karin, 2009). While cells must be able to rapidly respond to NF-kappa B stimuli, it is similarly important to restrain sustained high NF-kappa B levels that can trigger chronic inflammation or cellular transformation. Results published by Lu et al (2011) in this issue of The EMBO Journal identify a novel mechanism that amplifies NF-kappa B activity; NF-kappa B upregulates mir301a, a microRNA (miRNA) that itself blocks the expression of an NF-kappa B inhibitor. The resulting positive feedback mechanism potentiates NF-kappa B target gene expression. While this pathway may be important for normal cellular stress responses, the authors show that its sustained induction in pancreatic cancer cells leads to constitutive NF-kappa B activity that drives tumour progression.
引用
收藏
页码:1 / 2
页数:2
相关论文
共 50 条
  • [41] NF-κB inducing kinase (NIK) deletion accelerates the progression of pancreatic cancer
    Du, Ziwei
    Tsesmelis, Miltiadis
    Wirth, Thomas
    CANCER RESEARCH, 2022, 82 (22) : 39 - 40
  • [42] Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?
    Storz, Peter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 501 - 504
  • [43] Administration of NF-κB decoy inhibits pancreatic activation of NF-κB and prevents diabetogenesis by alloxan in mice
    Quan, N
    Ho, E
    Lai, WM
    Tsai, YH
    Bray, T
    FASEB JOURNAL, 2001, 15 (07): : 1616 - +
  • [44] Genistein inhibits NF-κB activity and NF-κB-mediated uPA expression
    Xu, J
    Loo, G
    FASEB JOURNAL, 2001, 15 (04): : A629 - A629
  • [45] Control of NF-κB Activity by Proteolysis
    Baud, Veronique
    Derudder, Emmanuel
    NF-KB IN HEALTH AND DISEASE, 2011, 349 : 97 - 114
  • [46] MINIMAL NF-κB ACTIVITY IN NEURONS
    Listwak, S. J.
    Rathore, P.
    Herkenham, M.
    NEUROSCIENCE, 2013, 250 : 282 - 299
  • [47] In vivo imaging of NF-κB activity
    Carlsen, H
    Moskaug, JO
    Fromm, SH
    Blomhoff, R
    JOURNAL OF IMMUNOLOGY, 2002, 168 (03): : 1441 - 1446
  • [48] NF-κB activation leads to chemoresistance in pancreatic cancers B
    Baerman, KM
    Dave-Coombe, K
    Baldwin, A
    Kim, HJ
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S86 - S86
  • [49] NF-κB Members Left Home: NF-κB-Independent Roles in Cancer
    Colomer, Carlota
    Marruecos, Laura
    Vert, Anna
    Bigas, Anna
    Espinosa, Lluis
    BIOMEDICINES, 2017, 5 (02)
  • [50] The ‘N-factors’ in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer
    A Arlt
    H Schäfer
    H Kalthoff
    Oncogenesis, 2012, 1 : e35 - e35